Brief: Ryvu Therapeutics To Get EUR 8 Mln Of Financing From EIB
June 18 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SAID ON MONDAY IT FULFILLED CONDITIONS FOR DISBURSEMENT OF
TRANCHE B OF FINANCING FROM EUROPEAN INVESTMENT BANK (EIB)
* FOLLOWING SAID FULFILMENT COMPANY EXPECT TO GET EUR 8.0
MLN ON
JUNE 25
* COMPANY IS REQUIRED TO REPAY TRANCHE B BY JUNE 25, 2029
Source text for Workspace: urn:newsml:reuters.com:*:nEM2lZmCCa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project